Selected References:
- Amstrong, C. 2008. ACOG Guidelines on Psychiatric Medication Use During Pregnancy and Lactation. Am Fam Physician; 78(6):772-778.
- Eberhard-Gran MM, et al. 2006. Use of psychotropic medications in treating mood disorders during lactation: practical recommendations. CNS Drugs; 20(3):187-98.
- Frey OR, et al. 1999. Adverse effects in a newborn infant breast-fed by a mother treated with doxepin. Ann Pharmacother; 33(6):690-3.
- Iqbal M. 1999. Effects of Antidepressants During Pregnancy and Lactation. Ann Clin Psychiatry; 11(4):237-56.
- Kemp J, et al. 198. Excretion of doxepin and N-desmethyldoxepin in human milk. Br J Clin Pharmacol 20:497-9.
- Kirchheiner J, et al. 2005. Impact of the CYP2D6 ultra-rapid metabolizer genotype on doxepin pharmacokinetics and serotonin in platelets. Pharmacogenet Genomics; 15(8):579–87.
- Matheson I, et al. 1985. Respiratory depression caused by N-desmethyldoxepin in breast milk. Lancet 2: 1124.
- McElhatton PR, et al. 1996. The outcome of pregnancy in 689 women exposed to therapeutic doses of antidepressants. A collaborative study of the European Network of Teratology Information Services (ENTIS). Reprod Toxicol; 10:285-94.
- Miller M, et al. 2020. Sleep Pharmacotherapy for Common Sleep Disorders in Pregnancy and Lactation. Chest; 157(1):184-197.
- Nulman I, et al. 1997. Neurodevelopment of children exposed in utero to antidepressant drugs. N Engl J Med; 336:258-62.
- Steiner M. 2012. Prenatal exposure to antidepressants: how safe are they? Am J Psychiatry; 169(11): 1130–1132.
- Venkatesh KK, et al. 2017. Impact of antidepressant treatment during pregnancy on obstetric outcomes among women previously treated for depression: an observational cohort study. J Perinatol; 37(9):1003-1009.
